Subscribe to Updates
Subscribe to our newsletter for the latest leadership tips, exclusive interviews, and expert advice from top CEOs. Simply enter your email below and stay ahead of the curve!.
Author: Daniel snow
Time to go short USD/JPY, questions Societe Generale Source link
Asia FX: yen near 18-mth low amid election talks, won reverses Bessent-backed jump Source link
Bessent says Korean won’s depreciation not in line with fundamentals Source link
Japan’s Takaichi election plans pressure yen- Citi Source link
Dollar stabilizes after losses; yen continues to weaken Source link
Asia FX: yen hits 1-1/2-yr low on Japan election talk; China trade data in focus Source link
Amgen CEO Bob Bradway told CNBC’s Jim Cramer he thinks his company’s obesity drug can help patients manage weight loss long term, which he indicated is a challenge.”We think we can address one of the reasons that the field is struggling a little bit, which is the patient persistence issue,” Bradway said. Amgen revealed Monday that a trial of its experimental GLP-1 drug, MariTide, showed that patients were able to maintain weight loss for two years when given a monthly injection. Right now, most widely-used weight loss injections are taken weekly. Bradway told Cramer that the pharmaceutical giant expects the…
U.S. dollar: Buy on the subpoena, sell on the indictment- StanChart Source link
USD/JPY: BofA sees yen weakness ahead of potential snap election Source link
China’s central bank likely to reverse FX measures as yuan strengthens Source link